LOIS FAIRFIELD: Open Payments
NPI 1104266212 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 16 payments from 11 companies in 2025. Trend: 2023 $13 · 2024 $192 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $114 |
| Novo Nordisk Inc | 1 | $83 |
| Amgen Inc. | 4 | $64 |
| CVRx, Inc. | 1 | $62 |
| Boston Scientific Corporation | 1 | $35 |
| Ionis Pharmaceuticals, Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
Products named: Kerendia, REPATHA, Barostim Neo System, General - Therapies, TRYNGOLZA, VERQUVO, LEQVIO, AREXVY.
Industry payments across GA — which companies pay providers there.
